Literature DB >> 12632021

Circulating tissue factor, tissue factor pathway inhibitor and D-dimer in umbilical cord blood of normal term neonates and adult plasma.

Siow-Phing Tay1, Soon-Keng Cheong, Nem-Yun Boo.   

Abstract

The investigation of many hemostatic defects in newborns is restricted by the lack of normal reference values. The coagulation system of the neonate differs in many ways from that of the adult. The present study was designed to compare the concentrations of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and D-dimer (DD) in the umbilical cord blood of healthy newborns and in adult plasma. TF antigen was quantified using an in-house enzyme-linked immunosorbent assay, whereas TFPI and DD levels were measured with commercial kits. The mean TF level in cord blood (mean standard deviation, 183.94 103.63 pg/ml) was significantly higher ( = 0.008) than that in adults (136.64 65.09 pg/ml). Cord blood exhibited enhanced fibrinolysis, as was reflected by a significantly higher level of DD (924.57 733.87 ng/ml, 0.001) than that in adults (45.57 17.21 ng/ml). Conversely, cord blood (30.88 10.16 ng/ml) demonstrated significantly lower ( 0.001) TFPI levels than that in adults (55.77 21.16 ng/ml). However, no significant differences of these three hemostatic markers were noted between both gender groups in newborns and adults. Our findings indicate that an active and dynamic state of hemostasis exists in cord blood, as the fluidity of cord blood remains preserved in the presence of birth injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12632021     DOI: 10.1097/00001721-200302000-00002

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation.

Authors:  Akira Shirahata; Jun Mimuro; Hoyu Takahashi; Isao Kitajima; Hajime Tsuji; Yutaka Eguchi; Tadashi Matsushita; Masahiro Kajiki; Goichi Honda; Yoichi Sakata
Journal:  Eur J Pediatr       Date:  2013-09-05       Impact factor: 3.183

2.  A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.

Authors:  Offer Erez; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Francesca Gotsch; Juan Pedro Kusanovic; Nandor Gabor Than; Shali Mazaki-Tovi; Edi Vaisbuch; Zoltan Papp; Bo Hyun Yoon; Yu Mi Han; Debra Hoppensteadt; Jawed Fareed; Sonia S Hassan; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-10

3.  Tissue factor and its natural inhibitor in pre-eclampsia and SGA.

Authors:  Offer Erez; Roberto Romero; Debra Hoppensteadt; Nandor Gabor Than; Jawed Fareed; Shali Mazaki-Tovi; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Sung-Su Kim; Bo Hyun Yoon; Sonia S Hassan; Francesca Gotsch; Lara Friel; Edi Vaisbuch; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2008-12

4.  Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.

Authors:  Salvatore Andrea Mastrolia; Moshe Mazor; Giuseppe Loverro; Vered Klaitman; Offer Erez
Journal:  PeerJ       Date:  2014-11-18       Impact factor: 2.984

5.  The Developing Balance of Thrombosis and Hemorrhage in Pediatric Surgery: Clinical Implications of Age-Related Changes in Hemostasis.

Authors:  Meredith A Achey; Uttara P Nag; Victoria L Robinson; Christopher R Reed; Gowthami M Arepally; Jerrold H Levy; Elisabeth T Tracy
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.